SVRA Stock Analysis: Buy, Sell, or Hold?

SVRA - Savara Inc.

PHARMACEUTICAL PREPARATIONS
$5.34
0.08 (1.52%) ▲
5d: +5.53%
30d: +1.33%
90d: +2.1%
BUY
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: May 12, 2026 0d

Get Alerted When SVRA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: SVRA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: SVRA is currently trading at $5.34, which is considered extended relative to its 30-day fair value range of $5.01 to $5.27.

Technical Outlook: Technically, SVRA is in a strong uptrend. Immediate support is located at $4.73, while resistance sits at $5.53.

Market Sentiment: SVRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.94 (+107.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $5.01 - $5.27
Company Quality Score 60/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 63.2%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 107.9% below Wall St target ($10.94)

Trading Range Analysis

30-Day Trading Range $5.01 - $5.27
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $4.73
Resistance Level $5.53
Current Trend Strong Uptrend
Technical data as of Jun 15, 2026

Fundamental Context

Forward P/E (Next Year Est.) -17.89
Wall Street Target $10.94 (+107.9%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 15, 2026 2:54 PM ET
Data refreshes hourly during market hours. Next update: 3:54 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for SVRA.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$439 57 HOLD
SRPT
Sarepta Therapeutics Inc
STRONG BUY
26 analysts
$22 52 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$34 67 BUY
INSM
Insmed Inc
STRONG BUY
21 analysts
$198 56 HOLD
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$84 53 HOLD

More Analysis for SVRA

SVRA Technical Chart SVRA Price Prediction SVRA Earnings Date SVRA Investment Advisor SVRA Fair Price Analyzer SVRA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals